品牌和通用tulobuterol补丁之间的机械和粘合差异在喘管理中的临床影响
Atsushi Ishimura1, HIna Tabayashi1, Motoki Inoue2
1Laboratory of Clinical Pharmacy Assessment, Hoshi University, Shinagawa, JPN.
Cureus
|December 15, 2025
概括
通用和品牌tulobuterol过皮贴片用于喘显示在机械和粘合性质的显著差异. 这些由辅助剂组成驱动的变化可能会影响可用性和患者对治疗的坚持.
科学领域:
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
- 药物输送系统 药物输送系统
背景情况:
- 在日本,tulobuterol透皮贴片被广泛用于喘管理.
- 了解品牌贴片和通用贴片之间的配方差异对于确保治疗等价性和患者合规性至关重要.
- 辅助剂的组成显著影响了皮肤间药物递送系统的物理性质和性能.
研究的目的:
- 评估和比较一个品牌的tulobuterol贴片和六种通用替代品的机械和粘合性质.
- 调查辅助剂成分对tulobuterol透皮贴片的可用性和性能的影响.
- 为了将配方差异与观察到的补丁特征变化相关联.
主要方法:
- 一个品牌和六个通用tulobuterol透皮贴片的分析.
- 使用单轴拉伸试验进行机械强度评估.
- 通过在受控环境条件下 (25°C,60%RH) 的球形探针脱落试验来评估粘合性能 (粘性).
- 从公开可用的包装插件中识别辅助剂组合物.
主要成果:
- 在机械性质和粘合性质方面观察到显著的配方依赖差异.
- 品牌补丁表现出刚性,在压力下早期破裂,而几种仿制药显示出更大的灵活性.
- 在通用药物中,粘度差异很大,有些药物具有过度的粘度,而另一些药物则具有不足的粘度,与粘合性聚合物和可塑剂相关.
结论:
- 品牌和通用tulobuterol透皮贴片具有独特的机械和粘合特性,尽管具有相当的药理动力学特征.
- 这些因助剂变异而产生的差异可能会影响临床可用性和患者在喘管理中的坚持.
- 该研究强调了在选择透皮喘药物时考虑辅助剂驱动的性能变化的重要性.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:23Inhaled Medications
687
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
687
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K